Top News and Analysis for R&D and Executive Leaders

 

Week of 5.14.08

tbar.gif


Best Practices
Click here to
submit entries

Neil W Gibson of OSI Pharmaceuticals

Jeffrey Settleman Harvard Medical School and MGH Cancer Center

David Bailey of Chemoventures

N Claude Cohen of Synergix

-View All Webcasts

 

 

 
     

 

 

Disclaimer, Terms, and Conditions


This site (www.PharmaWeek.com) is available for your use by Cambridge Healthtech Inc.’s PharmaWeek ("PharmaWeek") subject to the terms and conditions of this agreement (the "Agreement"). The information provided on this Site is provided by PharmaWeek and its third party suppliers ("Information Providers"). BY CONTINUING TO USE THE SITE, YOU ARE INDICATING YOUR AGREEMENT TO BE BOUND BY THE TERMS OF THIS AGREEMENT. IF YOU DO NOT AGREE, PHARMAWEEK IS NOT WILLING TO PROVIDE YOU WITH ACCESS TO THE SITE AND YOU SHOULD IMMEDIATELY DISCONTINUE YOUR USE OF THE SITE. PharmaWeek may modify this Agreement from time to time in its sole discretion and your continued use of the Site shall constitute acceptance of such modifications. 

Data provided on this Site may be delayed as specified by financial exchanges or Information Providers. PharmaWeek and Information Providers furnish the information available on this Site without responsibility for accuracy and you agree that errors contained in such information shall not be made the basis for any claim, demand or cause of action against PharmaWeek or any Information Provider. PharmaWeek believes its data and text services to be reliable, but accuracy is not warranted or guaranteed. The Site includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Neither PharmaWeek or its Information Providers guarantees the accuracy, completeness or timeliness of, or otherwise endorses, these views, opinions or recommendations, gives investment advice, or advocates the purchase or sale of any security or investment. 

You agree not to reproduce, retransmit, disseminate, sell, distribute, publish, broadcast, or otherwise commercially exploit the information available on this Site in any manner without the express written consent of PharmaWeek, nor to use the information available on this Site for any unlawful purpose. You agree to access the information available on this Site manually by request and not programmatically by macro or other automated means. PharmaWeek may point to other sites that may of be of interest to you but for which PharmaWeek has no responsibility. 

PHARMAWEEK AND ITS INFORMATION PROVIDERS EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR NON-INFRINGEMENT. 

NEITHER PHARMAWEEK NOR ANY OF ITS INFORMATION PROVIDERS, PARENTS, MEMBERS, SUBSIDIARIES, AFFILIATES, SERVICE PROVIDERS, LICENSORS, OFFICERS, DIRECTORS OR EMPLOYEES SHALL BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATING TO THIS AGREEMENT OR RESULTING FROM THE USE OR THE INABILITY TO USE THE SITE, INCLUDING BUT NOT LIMITED TO DAMAGES FOR LOSS OF PROFITS, USE, DATA OR OTHER INTANGIBLE DAMAGES, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. 

All information on this site is © 2005 Cambridge Healthtech Inc. or its Information Providers

 

DrugBank Database in Commercial Partnership

Deal with GenomeQuest exchanges access privileges, clinical data for funding.

By Kevin Davies
Bio-IT World

Feb. 1, 2008 | The Canadian developers of a popular drug database have partnered with a software company in an unusual win-win relationship. The deal exchanges short-term funding that might ensure the long-term survival of the database in return for exclusive data access to the commercial partner, GenomeQuest.

Read More

 


 


PharmaWeek
is subject to the terms and conditions of use
Please read the important legal notices and disclaimers contained in these terms and
conditions of use.


Copyright 2005  Cambridge Healthtech Institute  |  250 First Avenue  |   Suite 300   |   Needham,  MA  02494
Phone: 781-972-5400  |   Fax: 781-972-5425